|
6-hydroxydopamine(6-ohda) |
2 |
|
angiogenesis |
2 |
|
hyperhomocysteinemia |
2 |
|
methylnicotinamide |
2 |
|
mitochondrial dysfunction |
2 |
|
nicotinamide |
2 |
|
oxidative stress |
2 |
|
oxidativestress |
2 |
|
parkinson'sdisease |
2 |
|
schisantherin a |
2 |
|
vascular endothelial dysfunction |
2 |
|
zebrafish |
2 |
|
6-ohda |
1 |
|
aerobic glycolysis |
1 |
|
apoptosis |
1 |
|
atorvastatin |
1 |
|
autophagy |
1 |
|
benzofuran |
1 |
|
biopharmaceutical therapy |
1 |
|
breast cancer |
1 |
|
calcium channel |
1 |
|
calcium influx |
1 |
|
calcium sensitization |
1 |
|
carbonic anhydrase |
1 |
|
cardiovascular disease |
1 |
|
cerebral hemorrhage |
1 |
|
chemotherapy resistance |
1 |
|
chest blockage |
1 |
|
coronary disease |
1 |
|
coronary heart disease |
1 |
|
endothelial cell |
1 |
|
endothelial cell adhesion |
1 |
|
endothelium |
1 |
|
endothelium function |
1 |
|
eucommiae cortex |
1 |
|
fak/src/rac1 pathway |
1 |
|
ferulic acid |
1 |
|
flavonoids |
1 |
|
free radicals |
1 |
|
glucocorticoid |
1 |
|
glucose transporter |
1 |
|
hemoglobin |
1 |
|
hemorrhagic stroke |
1 |
|
huvecs |
1 |
|
hyperlipidemia |
1 |
|
hypoxia-inducible factor 1 |
1 |
|
inflammation |
1 |
|
iron channel |
1 |
|
itgα3 |
1 |
|
itgβ5 |
1 |
|
metastasis |
1 |
|
mitogen-activated protein kinases |
1 |
|
mpp + |
1 |
|
myocardial infarction |
1 |
|
na+/h+ exchanger |
1 |
|
natural product |
1 |
|
neoplasm |
1 |
|
neoplasms |
1 |
|
neovascularization |
1 |
|
neurodegeneration |
1 |
|
no |
1 |
|
osteoporosis |
1 |
|
osthole |
1 |
|
oxidized low density lipoprotein |
1 |
|
panax notoginseng flower |
1 |
|
parkinson disease |
1 |
|
plaque progression |
1 |
|
potassium channel |
1 |
|
pro-angiogenesis |
1 |
|
pyruvate kinase m2 |
1 |
|
radix achyranthis bidentatae |
1 |
|
rat organotypiccerebellarcultures |
1 |
|
rock |
1 |
|
ros |
1 |
|
salvia miltiorrhiza |
1 |
|
saponin |
1 |
|
sehm formula |
1 |
|
sodium tanshinone iia sulfonate |
1 |
|
spatholobi caulis |
1 |
|
su5416 |
1 |
|
tanshinone i |
1 |
|
tetrahydropalmatine |
1 |
|
timosaponin aiii |
1 |
|
traditional chinese herbal |
1 |
|
traditional chinese medicine |
1 |
|
transcription factor |
1 |
|
transcriptome |
1 |
|
tumor microenvironment |
1 |
|
vascular integrity |
1 |
|
vasorelaxation |
1 |
|
vegf |
1 |
|
vegf/pi3k/akt/mapk |
1 |
|
vsmc phenotype switching |
1 |
|
wenshen zhuanggu formula |
1 |
